ASX:RCE

RECCE PHARMACEUTICALS LTD

RECCE PHARMACEUTICALS LTD has not announced any capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

$100k - $250k

Investors Interested in Next Raise

10 - 25

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Company Overview

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

Level 36, Gateway, 1 Macquarie Pl, Sydney NSW 2000, Australia

Website

www.recce.com.au

Pharmaceuticals

Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Fresh Equities does not have RECCE PHARMACEUTICALS LTD quarterly cash flows data.